AEterna Zentaris Inc. (USA)


Stock Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Reports 1st Quarter 2015 Financial and Operating Results

AEterna Zentaris Inc. (USA) (NASDAQ: AEZS), a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health, reported …

Canaccord Slashes Price Target for AEterna Zentaris Inc. (USA) Following 4Q:14 Results

Canaccord Genuity analyst Neil Maruoka came out with a research note on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), reducing the price target to $0.

Maxim Reiterates Buy on AEterna Zentaris Inc. (USA) Following 4Q:14 Update

Maxim Group's healthcare analyst Jason Kolbert came out with a research note on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the company reported its fourth-quarter financial results and provided a corporate …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts